ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Funding Round

by NASDAQ Market News June 15, 2021

NASDAQ Market News
Click here to email author

Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Guide Preparation for Late-Stage Clinical Trials of LB1148 in Accelerating Postoperative Return of Bowel Function and Reduction of Post-Surgical Adhesions

Oncorus to Host Investor Day Featuring its IV-Administered Synthetic Viral RNA (vRNA) Immunotherapy Platform and Lead Synthetic vRNA Product Candidates

Ads